The present invention relates to novel crystalline forms ´ and µ of Silodosin and to methods for their preparation. Furthermore the present invention relates to the use of form ´ for the preparation of form ² and form µ. In addition the present invention relates to pharmaceutical compositions comprising an effective amount of crystalline form ´ and/or µ of Silodosin.